Tuesday, April 30, 2013 3:44:45 PM
Dr Menon, who is affiliated with the Company, did several sets of influenza studies using the standard model as well as a few sets of HIV studies using the SCID-Hu Thy/Liv standard model. The staff at the Vietnam National Laboratory did the initial influenza studies. The initial HIV studies were done at Beth Israel Hospital in Boston.
In addition, Dr. Harris (considered the leading dengue researcher in the US) did the dengue hemorrhagic fever studies on a mouse model of her own design. She salvaged 50% of the animals who had dengue hemorrhagic fever, a lethal disease in her model. That was her first pass at the drug, without optimization.
Dr. Diwan has presented at multiple scientific conferences, including one sponsored by NIST, the National Institute of Standards and Technology. And also more recently at a seminar hosted by the Center for Biological Physics, jointly with the California NanoSystems Institute, a name of some prestige.
Although there has been no interest in publishing, they did write a chapter in a scientific book about nanotechnology but only because they were asked to do so.
Incidentally, between all of the principals, they have taken 12 drugs to market, have published hundreds of papers and have something in the neighborhood of 45 patents.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM